| Literature DB >> 29080263 |
Spencer C Knight1, Robert Tjian2,3,4,5, Jennifer A Doudna1,2,3,4,6,7.
Abstract
The discovery of the CRISPR-Cas9 endonuclease has enabled facile genome editing in living cells and organisms. Catalytically inactive Cas9 (dCas9) retains the ability to bind DNA in an RNA-guided fashion, and has additionally been explored as a tool for transcriptional modulation, epigenetic editing, and genome imaging. This Review highlights recent progress and challenges in the development of dCas9 for imaging genomic loci. The emergence and maturation of this technology offers the potential to answer mechanistic questions about chromosome dynamics and three-dimensional genome organization in vivo.Entities:
Keywords: 3D genome organization; CRISPR; genome editing; imaging; microscopy
Mesh:
Substances:
Year: 2018 PMID: 29080263 PMCID: PMC6014596 DOI: 10.1002/anie.201709201
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336